Guide
If you are operating a 21 CFR Part 11 compliant laboratory and want to use electronic signatures, there are certain steps you must follow to declare that signatures used on records are legally binding equivalents to handwritten signatures.
We have developed our AuditSafe 21 CFR Part 11 compliance software to give labs the audit trails and electronic signatures required by FDA’s 21 CFR part 11 regulations.
Please note, before reading the below information we do not represent any government agency and nothing in this guide should be taken as fact. The information we provide is accurate as of the publishing date. You should check FDA guidelines and regulations for implementing your own electronic signatures.
21 CFR part 11 requirements
The following text is taken directly from the Title CFR 21 Part 11 guidelines. The complete regulations can be found on the U.S. Food and Drug Administration (FDA) website.
“Before using electronic signatures, or at the time of use, persons using electronic signatures must certify to the Agency the electronic signatures used in their system on or after August 20, 1997, are intended to be the legally binding equivalent of handwritten signatures.
“The above-mentioned certifications must be in paper form and signed with handwritten signatures and submitted to ORO/DEIO (HFC-130).
“On request, persons must provide additional certification or testimony that a specific electronic signature is the legally binding equivalent of the signers handwritten signature.”
Key takeaways
The certificate must be submitted to the FDA in writing prior to assigning that individual’s electronic signature. A certificate can broadly cover the electronic signature of all current and
future employees and may not be required for individual persons.
An organization should also confirm the identification of the individuals using electronic signatures. The FDA does not specify any particular method for verifying the identity of an
individual and accepts many different methods.
Electronic signatures are only one part of the regulation. Our 21 CFR Part 11 compliance guide also covers the audit trail, access control and validation requirements.
Next steps
Setting up your electronic signatures for the FDA can be an easy process, following our guidelines above can be used as a starting point for your compliance needs. If you would like a demonstration of AuditSafe to help your compliance with 21 CFR Part 11 for life science organizations operating in GMP/GLP labs, get in touch.
Keep reading
- Checklist21 CFR part 11/GMP compliance checklistWe have created this 21 CFR part 11 compliance checklist to ensure you are have the right checks in place to comply with the regulations.
- Guide21 CFR Part 11 Compliance GuideCompliance with FDA 21 CFR Part 11 is critical for life science laboratories relying on electronic records and signatures. In this comprehensive technical guide, we break down how our AuditSafe software helps users achieve the regulatory requirements of Subpart B, EU Annex 11, GMP and ALCOA data integrity principles. Download the guide to discover how TotalLab's AuditSafe software seamlessly enforces compliance and secures your digital workflows.
- GuideHow AuditSafe Meets 21 CFR Part 11 and EU Annex 11, Clause by ClauseEvery Part 11 requirement, what AuditSafe does about it, and what stays with your lab. Built for URS and supplier-audit questions.
Your software won't do what you need? Ask TotalLab →Tell us the problem; we reply within two working days.
